• 1645 Citations
  • 22 Scopus h-Index
20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 1645 Citations
  • 22 Scopus h-Index
  • 53 Article
  • 9 Review article
  • 3 Letter
  • 1 Comment/debate
2020

Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study

Modi, S., Park, H., Murthy, R. K., Iwata, H., Tamura, K., Tsurutani, J., Moreno-Aspitia, A., Doi, T., Sagara, Y., Redfern, C., Krop, I. E., Lee, C., Fujisaki, Y., Sugihara, M., Zhang, L., Shahidi, J. & Takahashi, S., Jun 10 2020, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38, 17, p. 1887-1896 10 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

A pooled analysis of the cardiac events in the trastuzumab adjuvant trials

de Azambuja, E., Ponde, N., Procter, M., Rastogi, P., Cecchini, R. S., Lambertini, M., Ballman, K., Aspitia, A. M., Zardavas, D., Roca, L., Gelber, R. D., Piccart-Gebhart, M. & Suter, T., Jan 1 2020, In : Breast Cancer Research and Treatment. 179, 1, p. 161-171 11 p.

Research output: Contribution to journalArticle

5 Scopus citations

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial

Eiger, D., Pondé, N. F., Agbor-Tarh, D., Moreno-Aspitia, A., Piccart, M., Hilbers, F. S., Werner, O., Chumsri, S., Dueck, A., Kroep, J. R., Gomez, H., Láng, I., Rodeheffer, R. J., Ewer, M. S., Suter, T. & de Azambuja, E., May 12 2020, In : British journal of cancer. 122, 10, p. 1453-1460 8 p.

Research output: Contribution to journalArticle

N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer

Leon-Ferre, R. A., Perez, E. A., Hillman, D. W., Bueno, C., Perez, A. T., Chen, B., Jenkins, R. B., Northfelt, D. W., Johnson, D. B., Carolla, R. L., Zon, R. T. & Moreno-Aspitia, A., Aug 1 2020, In : Breast Cancer Research and Treatment. 182, 3, p. 613-622 10 p.

Research output: Contribution to journalArticle

Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)

Sharma, M. R., Mehrotra, S., Gray, E., Wu, K., Barry, W. T., Hudis, C., Winer, E. P., Lyss, A. P., Toppmeyer, D. L., Moreno-Aspitia, A., Lad, T. E., Velasco, M., Overmoyer, B., Rugo, H. S., Ratain, M. J. & Gobburu, J. V., Apr 1 2020, In : Journal of Clinical Pharmacology. 60, 4, p. 444-452 9 p.

Research output: Contribution to journalArticle

2019

Adjuvant Anti-HER2 Therapy, treatment-related amenorrhea, and survival in premenopausal HER2-positive early breast cancer patients

Lambertini, M., Campbell, C., Bines, J., Korde, L. A., Izquierdo, M., Fumagalli, D., Del Mastro, L., Ignatiadis, M., Pritchard, K., Wolff, A. C., Jackisch, C., Lang, I., Untch, M., Smith, I., Boyle, F., Xu, B., Barrios, C. H., Baselga, J., Moreno-Aspitia, A., Piccart, M. & 2 others, Gelber, R. D. & De Azambuja, E., Jan 1 2019, In : Journal of the National Cancer Institute. 111, 1, djy094.

Research output: Contribution to journalArticle

19 Scopus citations

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

Dudenkov, T. M., Liu, D., Cairns, J., Devarajan, S., Zhuang, Y., Ingle, J. N., Buzdar, A. U., Robson, M. E., Kubo, M., Batzler, A., Barman, P., Jenkins, G. D., Carlson, E. E., Goetz, M. P., Northfelt, D. W., Moreno-Aspitia, A., Desta, Z., Reid, J. M., Kalari, K. R., Wang, L. & 1 others, Weinshilboum, R. M., Jul 2019, In : Clinical pharmacology and therapeutics. 106, 1, p. 219-227 9 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trial

Holmes, E. M., Bradbury, I., Williams, L. S., Korde, L., De Azambuja, E., Fumagalli, D., Moreno-Aspitia, A., Baselga, J., Piccart-Gebhart, M., Dueck, A. C. & Gelber, R. D., Sep 1 2019, In : Annals of Oncology. 30, 9, p. 1507-1513 7 p.

Research output: Contribution to journalArticle

1 Scopus citations

Comparison of 99mTc-sestamibi molecular breast imaging and breast MRI in patients with invasive breast cancer receiving neoadjuvant chemotherapy

Hunt, K. N., Conners, A. L., Goetz, M. P., O’Connor, M. K., Suman, V., Kalari, K., Weinshilboum, R., Wang, L., Carter, J., McLaughlin, S. A., Aspitia, A. M., Gray, R. J., Northfelt, D. & Boughey, J. C., Jan 1 2019, In : American Journal of Roentgenology. 213, 4, p. 932-943 12 p.

Research output: Contribution to journalArticle

2 Scopus citations

Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial

Lambertini, M., Campbell, C., Gelber, R. D., Viale, G., McCullough, A. E., Hilbers, F., Korde, L. A., Werner, O., Chumsri, S., Jackisch, C., Wolff, A. C., Vaz-Luis, I., Ferreira, A. R., Prat, A., Moreno-Aspitia, A., Piccart, M., Loi, S. & de Azambuja, E., Aug 30 2019, In : Breast Cancer Research and Treatment. 177, 1, p. 103-114 12 p.

Research output: Contribution to journalArticle

4 Scopus citations

Effects of age and immune landscape on outcome in HER2-positive breast cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) trials

Chumsri, S., Serie, D. J., Li, Z., Pogue-Geile, K. L., Soyano-Muller, A. E., Mashadi-Hossein, A., Warren, S., Lou, Y., Colon-Otero, G., Knutson, K. L., Perez, E. A., Moreno-Aspitia, A. & Thompson, E. A., Jan 1 2019, In : Clinical Cancer Research. 25, 14, p. 4422-4430 9 p.

Research output: Contribution to journalArticle

1 Scopus citations

Incidence of late relapses in patients with HER2-positive breast cancer receiving adjuvant trastuzumab: Combined analysis of NCCTG N9831 (Alliance) and NRG oncology/NSABP B-31

Chumsri, S., Li, Z., Serie, D. J., Mashadi-Hossein, A., Colon-Otero, G., Song, N., Pogue-Geile, K. L., Gavin, P. G., Paik, S., Moreno-Aspitia, A., Perez, E. A. & Aubrey Thompson, E., Jan 1 2019, In : Journal of Clinical Oncology. 37, 35, p. 3425-3435 11 p.

Research output: Contribution to journalArticle

1 Scopus citations
2018

AlternativeOutpatientChemotherapy scheduling method to improve patient service quality and nurse satisfaction

Huang, Y. L., Bryce, A. H., Culbertson, T., Connor, S. L., Looker, S. A., Altman, K. M., Collins, J. G., Stellner, W., Mc Williams, R. R., Moreno Aspitia, A., Ailawadhi, S. & Mesa, R. A., Feb 1 2018, In : Journal of Oncology Practice. 14, 2, p. e82-e91

Research output: Contribution to journalArticle

1 Scopus citations

DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine

Yu, J., Qin, B., Moyer, A. M., Nowsheen, S., Liu, T., Qin, S., Zhuang, Y., Liu, D., Lu, S. W., Kalari, K. R., Visscher, D. W., Copland, J. A., McLaughlin, S. A., Moreno-Aspitia, A., Northfelt, D. W., Gray, R. J., Lou, Z., Suman, V. J., Weinshilboum, R., Boughey, J. C. & 2 others, Goetz, M. P. & Wang, L., Jun 1 2018, In : Journal of Clinical Investigation. 128, 6, p. 2376-2388 13 p.

Research output: Contribution to journalArticle

26 Scopus citations

High p95HER2/HER2 ratio associated with poor outcome in trastuzumab-treated HER2-positive metastatic breast cancer ncctg N0337 and NCCTG 98-32-52 (Alliance)

Chumsri, S., Sperinde, J., Liu, H., Gligorov, J., Spano, J. P., Antoine, M., Aspitia, A. M., Tan, W., Winslow, J., Petropoulos, C. J., Chenna, A., Bates, M., Weidler, J. M., Huang, W., Dueck, A. & Perez, E. A., Jul 1 2018, In : Clinical Cancer Research. 24, 13, p. 3053-3058 6 p.

Research output: Contribution to journalArticle

2 Scopus citations

Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials

Lambertini, M., Martel, S., Campbell, C., Guillaume, S., Hilbers, F. S., Schuehly, U., Korde, L., Azim, H. A., Di Cosimo, S., Tenglin, R. C., Huober, J., Baselga, J., Moreno Aspitia, A., Piccart-Gebhart, M., Gelber, R. D., de Azambuja, E. & Ignatiadis, M., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

11 Scopus citations
2017

Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527

Freedman, R. A., Foster, J. C., Seisler, D. K., Lafky, J. M., Muss, H. B., Cohen, H. J., Mandelblatt, J., Winer, E. P., Hudis, C. A., Partridge, A. H., Carey, L. A., Cirrincione, C., Moreno-Aspitia, A., Kimmick, G., Jatoi, A. & Hurria, A., Feb 1 2017, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 4, p. 421-431 11 p.

Research output: Contribution to journalArticle

29 Scopus citations

Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial (Breast Cancer Research and Treatment, (2017), 165, 2, (329-341), 10.1007/s10549-017-4304-7)

Cortés, J., Rugo, H. S., Awada, A., Twelves, C., Perez, E. A., Im, SA. A., Gómez-Pardo, P., Schwartzberg, L. S., Diéras, V., Yardley, D. A., Potter, D. A., Mailliez, A., Moreno-Aspitia, A., Ahn, J. S., Zhao, C., Hoch, U., Tagliaferri, M., Hannah, A. L. & O’Shaughnessy, J., Nov 1 2017, In : Breast Cancer Research and Treatment. 166, 1, p. 327-328 2 p.

Research output: Contribution to journalComment/debate

Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

Yu, J., Qin, B., Moyer, A. M., Sinnwell, J. P., Thompson, K. J., Copland, J. A., Marlow, L. A., Miller, J. L., Yin, P., Gao, B., Minter-Dykhouse, K., Tang, X., McLaughlin, S. A., Moreno-Aspitia, A., Schweitzer, A., Lu, Y., Hubbard, J., Northfelt, D. W., Gray, R. J., Hunt, K. & 10 others, Conners, A. L., Suman, V. J., Kalari, K. R., Ingle, J. N., Lou, Z., Visscher, D. W., Weinshilboum, R., Boughey, J. C., Goetz, M. P. & Wang, L., Dec 6 2017, In : Breast cancer research : BCR. 19, 1, 1 p.

Research output: Contribution to journalArticle

17 Scopus citations

Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial

Twelves, C., Cortés, J., O'Shaughnessy, J., Awada, A., Perez, E. A., Im, SA. A., Gómez-Pardo, P., Schwartzberg, L. S., Diéras, V., Yardley, D. A., Potter, D. A., Mailliez, A., Moreno-Aspitia, A., Ahn, J. S., Zhao, C., Hoch, U., Tagliaferri, M., Hannah, A. L. & Rugo, H. S., May 1 2017, In : European Journal of Cancer. 76, p. 205-215 11 p.

Research output: Contribution to journalArticle

8 Scopus citations

Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2-positive primary breast cancer: Analysis from the ALTTO phase III randomized trial

Sonnenblick, A., Agbor-Tarh, D., Bradbury, I., Di Cosimo, S., Azim, H. A., Fumagalli, D., Sarp, S., Wolff, A. C., Andersson, M., Kroep, J., Cufer, T., Simon, S. D., Salman, P., Toi, M., Harris, L., Gralow, J., Keane, M., Moreno Aspitia, A., Piccart-Gebhart, M. & De Azambuja, E., May 1 2017, In : Journal of Clinical Oncology. 35, 13, p. 1421-1429 9 p.

Research output: Contribution to journalArticle

40 Scopus citations

Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance)

Mehrotra, S., Sharma, M. R., Gray, E., Wu, K., Barry, W. T., Hudis, C., Winer, E. P., Lyss, A. P., Toppmeyer, D. L., Moreno-Aspitia, A., Lad, T. E., Valasco, M., Overmoyer, B., Rugo, H., Ratain, M. J. & Gobburu, J. V., Sep 1 2017, In : AAPS Journal. 19, 5, p. 1411-1423 13 p.

Research output: Contribution to journalArticle

5 Scopus citations

Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial

Cortés, J., Rugo, H. S., Awada, A., Twelves, C., Perez, E. A., Im, S., Gómez-Pardo, P., Schwartzberg, L. S., Diéras, V., Yardley, D. A., Potter, D. A., Mailliez, A., Moreno-Aspitia, A., Ahn, J. S., Zhao, C., Hoch, U., Tagliaferri, M., Hannah, A. L. & O’Shaughnessy, J., Sep 1 2017, In : Breast Cancer Research and Treatment. 165, 2, p. 329-341 13 p.

Research output: Contribution to journalArticle

22 Scopus citations

Regional Nodal Irradiation after Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis from the ALTTO Trial

Gingras, I., Holmes, E., De Azambuja, E., Nguyen, D. H. A., Izquierdo, M., Zujewski, J. A., Inbar, M., Naume, B., Tomasello, G., Gralow, J. R., Wolff, A. C., Harris, L., Gnant, M., Moreno Aspitia, A., Piccart, M. J. & Azim, H. A., Aug 1 2017, In : Journal of the National Cancer Institute. 109, 8, djw331.

Research output: Contribution to journalArticle

6 Scopus citations

Rifaximin for pertuzumab-related GI toxicities

Soyano, A. E., Reynolds, G., Moreno Aspitia, A. & Chumsri, S., Aug 8 2017, In : Frontiers in Oncology. 7, AUG, p. 168 1 p.

Research output: Contribution to journalArticle

3 Scopus citations

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer

Goetz, M. P., Kalari, K. R., Suman, V. J., Moyer, A. M., Yu, J., Visscher, D. W., Dockter, T. J., Vedell, P. T., Sinnwell, J. P., Tang, X., Thompson, K. J., McLaughlin, S. A., Moreno-Aspitia, A., Copland, J. A., Northfelt, D. W., Gray, R. J., Hunt, K., Conners, A., Weinshilboum, R., Wang, L. & 1 others, Boughey, J. C., Jul 1 2017, In : Journal of the National Cancer Institute. 109, 7, djw306.

Research output: Contribution to journalArticle

23 Scopus citations
2016

Assessment of tumor heterogeneity, as evidenced by gene expression profiles, pathway activation, and gene copy number, in patients with multifocal invasive lobular breast tumors

Norton, N., Advani, P. P., Serie, D. J., Geiger, X. J., Necela, B. M., Axenfeld, B. C., Kachergus, J. M., Feathers, R. W., Carr, J. M., Crook, J., Moreno Aspitia, A., Anastasiadis, P. Z., Perez, E. A. & Thompson, E. A., Apr 1 2016, In : PLoS One. 11, 4, e0153411.

Research output: Contribution to journalArticle

14 Scopus citations

Phase i Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients

Tan, W., Allred, J. B., Moreno Aspitia, A., Northfelt, D. W., Ingle, J. N., Goetz, M. P. & Perez, E. A., Apr 1 2016, In : Clinical Breast Cancer. 16, 2, p. 82-86 5 p.

Research output: Contribution to journalArticle

17 Scopus citations
2015

A phase II study of AZD2171 (cediranib) in the treatment of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome

Mattison, R., Jumonville, A., Flynn, P. J., Moreno-Aspitia, A., Erlichman, C., Laplant, B. & Juckett, M. B., Jul 1 2015, In : Leukemia and Lymphoma. 56, 7, p. 2061-2066 6 p.

Research output: Contribution to journalArticle

7 Scopus citations

Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors

Necela, B. M., Crozier, J. A., Andorfer, C. A., Lewis-Tuffin, L., Kachergus, J. M., Geiger, X. J., Kalari, K. R., Serie, D. J., Sun, Z., Moreno-Aspitia, A., O'Shannessy, D. J., Maltzman, J. D., McCullough, A. E., Pockaj, B. A., Cunliffe, H. E., Ballman, K. V., Thompson, E. A. & Perez, E. A., Apr 30 2015, In : PLoS One. 10, 4, e0127133.

Research output: Contribution to journalArticle

4 Scopus citations

Dual HER2 blockade in the neoadjuvant and adjuvant treatment of HER2-positive breast cancer

Advani, P., Cornell, L., Chumsri, S. & Moreno Aspitia, A., Sep 22 2015, In : Breast Cancer: Targets and Therapy. 7, p. 321-335 15 p.

Research output: Contribution to journalArticle

11 Scopus citations

Etirinotecan pegol (NKTR-102) versus treatment of physician's choice in women with advanced breast cancer previously treated with an anthracycline, a taxane, and capecitabine (BEACON): A randomised, open-label, multicentre, phase 3 trial

Perez, E. A., Awada, A., O'Shaughnessy, J., Rugo, H. S., Twelves, C., Im, S. A., Gómez-Pardo, P., Schwartzberg, L. S., Diéras, V., Yardley, D. A., Potter, D. A., Mailliez, A., Moreno Aspitia, A., Ahn, J. S., Zhao, C., Hoch, U., Tagliaferri, M., Hannah, A. L. & Cortes, J., 2015, In : The Lancet Oncology. 16, 15, p. 1556-1568 13 p.

Research output: Contribution to journalArticle

50 Scopus citations

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy

Ellingson, M. S., Hart, S. N., Kalari, K. R., Suman, V., Schahl, K. A., Dockter, T. J., Felten, S. J., Sinnwell, J. P., Thompson, K. J., Tang, X., Vedell, P. T., Barman, P., Sicotte, H., Eckel-Passow, J. E., Northfelt, D. W., Gray, R. J., McLaughlin, S. A., Moreno-Aspitia, A., Ingle, J. N., Moyer, A. M. & 9 others, Visscher, D. W., Jones, K., Conners, A., McDonough, M., Wieben, E. D., Wang, L., Weinshilboum, R., Boughey, J. C. & Goetz, M. P., Sep 7 2015, In : Breast Cancer Research and Treatment. 153, 2, p. 435-443 9 p.

Research output: Contribution to journalArticle

11 Scopus citations

N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy

Crozier, J. A., Advani, P. P., Laplant, B., Hobday, T. J., Jaslowski, A. J., Moreno Aspitia, A. & Perez, E. A., May 18 2015, (Accepted/In press) In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

19 Scopus citations

Randomized phase III trial of paclitaxel once per week compared with nanoparticle albumin-bound nab-paclitaxel once per week or ixabepilone with bevacizumab as first-line chemotherapy for locally recurrent or metastatic breast cancer: CALGB 40502/NCCTG N063H (Alliance)

Rugo, H. S., Barry, W. T., Moreno Aspitia, A., Lyss, A. P., Cirrincione, C., Leung, E., Mayer, E. L., Naughton, M., Toppmeyer, D., Carey, L. A., Perez, E. A., Hudis, C. & Winer, E. P., Jul 20 2015, In : Journal of Clinical Oncology. 33, 21, p. 2361-2369 9 p.

Research output: Contribution to journalArticle

97 Scopus citations
2014

Adjuvant chemotherapy in breast cancer: To use or not to use, the anthracyclines

Crozier, J. A., Swaika, A. & Moreno Aspitia, A., Aug 10 2014, In : World Journal of Clinical Oncology. 5, 3, p. 529-538 10 p.

Research output: Contribution to journalArticle

41 Scopus citations

Current strategies for the prevention of breast cancer

Advani, P. & Moreno-Aspitia, A., 2014, In : Breast Cancer: Targets and Therapy. 6, p. 59-71 13 p.

Research output: Contribution to journalReview article

31 Scopus citations
2013

Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831

Crozier, J. A., Moreno-Aspitia, A., Ballman, K. V., Dueck, A. C., Pockaj, B. A. & Perez, E. A., Jul 1 2013, In : Cancer. 119, 13, p. 2447-2454 8 p.

Research output: Contribution to journalArticle

22 Scopus citations

RC0639: Phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer

Moreno-Aspitia, A., Dueck, A. C., Ghanem-Cañete, I., Patel, T., Dakhil, S., Johnson, D., Franco, S., Kahanic, S., Colon-Otero, G., Tenner, K. S., Rodeheffer, R., McCullough, A. E., Jenkins, R. B., Palmieri, F. M., Northfelt, D. & Perez, E. A., Apr 1 2013, In : Breast Cancer Research and Treatment. 138, 2, p. 427-435 9 p.

Research output: Contribution to journalArticle

13 Scopus citations

Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: Results from North Central Cancer Treatment Group adjuvant trial N9831

Moreno-Aspitia, A., Hillman, D. W., Dyar, S. H., Tenner, K. S., Gralow, J., Kaufman, P. A., Davidson, N. E., Lafky, J. M., Reinholz, M. M., Lingle, W. L., Kutteh, L. A., Carney, W. P., Dueck, A. C. & Perez, E. A., Aug 1 2013, In : Cancer. 119, 15, p. 2675-2682 8 p.

Research output: Contribution to journalArticle

31 Scopus citations
2012

A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans

Colon-Otero, G., Albertie, M., Lesperance, M., Weis, J. A., Coles, A., Smith, N., Mills, L., Woodward, T., Aspitia, A. M., Vishnu, P., Willis, F., Isley, A., Fonseca, R., Vachon, C. & Rajkumar, S. V., Jun 1 2012, In : Journal of Cancer Education. 27, 2, p. 294-298 5 p.

Research output: Contribution to journalArticle

6 Scopus citations

Neoadjuvant therapy in early-stage breast cancer

Moreno-Aspitia, A., May 1 2012, In : Critical Reviews in Oncology/Hematology. 82, 2, p. 187-199 13 p.

Research output: Contribution to journalReview article

14 Scopus citations
2011

Cytokeratin-19 and Mammaglobin gene expression in circulating tumor cells from metastatic breast cancer patients enrolled in North Central Cancer Treatment Group trials, N0234/336/436/437

Reinholz, M. M., Kitzmann, K. A., Tenner, K., Hillman, D., Dueck, A. C., Hobday, T. J., Northfelt, D. W., Moreno-Aspitia, A., Roy, V., LaPlant, B., Allred, J. B., Stella, P. J., Lingle, W. L. & Perez, E. A., Nov 15 2011, In : Clinical Cancer Research. 17, 22, p. 7183-7193 11 p.

Research output: Contribution to journalArticle

46 Scopus citations
3 Scopus citations

Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer

Perez, E. A., Suman, V. J., Davidson, N. E., Gralow, J. R., Kaufman, P. A., Visscher, D. W., Chen, B., Ingle, J. N., Dakhil, S. R., Zujewski, J. A., Moreno-Aspitia, A., Pisansky, T. M. & Jenkins, R. B., Dec 1 2011, In : Journal of Clinical Oncology. 29, 34, p. 4491-4497 7 p.

Research output: Contribution to journalArticle

191 Scopus citations

The definition of IgM multiple myeloma

Schuster, S. R., Rajkumar, S. V., Dispenzieri, A., Morice, W., Aspitia, A. M., Ansell, S., Kyle, R. & Mikhael, J., Aug 1 2011, In : American journal of hematology. 86, 8, p. 718-719 2 p.

Research output: Contribution to journalLetter

1 Scopus citations
2010

Adjuvant therapy of triple negative breast cancer

Perez, E. A., Moreno-Aspitia, A., Thompson, E. A. & Andorfer, C. A., Apr 1 2010, In : Breast Cancer Research and Treatment. 120, 2, p. 285-291 7 p.

Research output: Contribution to journalReview article

39 Scopus citations

Clinical overview of sorafenib in breast cancer

Moreno-Aspitia, A., May 1 2010, In : Future Oncology. 6, 5, p. 655-663 9 p.

Research output: Contribution to journalReview article

19 Scopus citations

Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer

Perez, E. A., Patel, T. & Moreno-Aspitia, A., Jun 1 2010, In : Breast Cancer Research and Treatment. 121, 2, p. 261-271 11 p.

Research output: Contribution to journalReview article

60 Scopus citations

IgM multiple myeloma: Disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia

Schuster, S. R., Rajkumar, S. V., Dispenzieri, A., Morice, W., Aspitia, A. M., Ansell, S., Kyle, R. & Mikhael, J., Nov 1 2010, In : American journal of hematology. 85, 11, p. 853-855 3 p.

Research output: Contribution to journalArticle

53 Scopus citations